Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
14083 Dissertation_RaymondJL.pdf (7.82 MB)
ETD Abstract Container
Abstract Header
Bioactive gas encapsulation and release from echogenic liposomes
Author Info
Raymond, Jason L
ORCID® Identifier
http://orcid.org/0000-0002-6367-9431
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=ucin1429272100
Abstract Details
Year and Degree
2015, PhD, University of Cincinnati, Engineering and Applied Science: Biomedical Engineering.
Abstract
Cardiovascular disease (CVD) is the leading cause of death worldwide, and the economic impact of CVD is expected to increase substantially in future decades as disability rates due to ischemic heart disease and stroke rise. More effective diagnostic tools and therapies are necessary to limit the growing burden of CVD, particularly those which manifest in clotting within the arteries of the heart or brain. Echogenic liposomes (ELIP) are nanoparticle theragnostic agents being developed to target and treat cardiovascular disease. ELIP contain a small amount of gas and can function as an injectable ultrasound contrast agent (UCA) to improve visualization of the heart or diseased arteries. Previous investigations have shown that it is possible to load ELIP with bioactive gases, and that pulsed ultrasound exposure can result in the loss of echogenicity from ELIP. The purpose of this study was to determine if pulsed ultrasound exposure can also be used for controlled release of gas from ELIP. Determining the relationship between microbubble activity and acoustically-induced gas release will help to develop a method utilizing ELIP as therapeutic agents for delivery of gas to tissue. In Chapters 2 and 3, acoustic methods were used to characterize a series of novel formulations of ELIP with different shell components and gas content. Estimates of the shell properties of ELIP, as well as two commercially available UCAs, Definity® and MicroMarker®, were obtained using a linearized viscoelastic acoustic scattering model. Overall, ELIP are characterized by higher shell elasticity and shell damping coefficient than the commercially available agents. Replacing air with the high molecular weight gas octafluoropropane and addition of polyethylene glycol into the shell formulation resulted in longer stability and improved high-frequency response, making these ELIP formulations particularly suitable for intravascular ultrasound applications. In addition, ELIP encapsulating octafluoropropane and two physiologically active gases, nitric oxide and xenon, were investigated. It was shown that encapsulation of nitric oxide has a strong and prolonged osmotic effect whereas ELIP containing xenon gas were relatively stable in vitro. In Chapters 4 and 5, an ultra-high-speed optical imaging approach was used to investigate the acoustic response of ELIP to both short-pulse and multiple-cycle tone burst insonations. The acoustic response and viscoelastic shell properties of ELIP were found to be similar to other phospholipid-shelled UCAs. A decrease in shell viscosity was observed with increasing dilatation rate, indicative of shear-thinning behavior. ELIP are stable when exposed to short-pulse insonations similar to those used in echocardiography, and can therefore be used as an echocontrast agent for cardiovascular imaging applications. For tone burst insonations it was shown that the maximum dilatation rate correlates with loss of gas due to acoustically-driven diffusion, and a threshold was identified for loss of gas due to this effect. These studies demonstrated that ELIP can be considered a theragnostic agent, with both stable and unstable dynamics that can be exploited using different ultrasound parameter regimes. The observed phenomena of ultrasound-induced loss of gas could be exploited to optimize ELIP for therapeutic delivery of gas to tissue.
Committee
Christy Holland, Ph.D. (Committee Chair)
Todd Abruzzo, Ph.D. (Committee Member)
Nico de Jong, Ph.D. (Committee Member)
Shaoling Huang, Ph.D. (Committee Member)
T. Douglas Mast, Ph.D. (Committee Member)
Pages
170 p.
Subject Headings
Biomedical Research
Keywords
ultrasound
;
contrast agent
;
microbubble
;
cavitation
;
liposome
;
acoustically driven diffusion
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Raymond, J. L. (2015).
Bioactive gas encapsulation and release from echogenic liposomes
[Doctoral dissertation, University of Cincinnati]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1429272100
APA Style (7th edition)
Raymond, Jason.
Bioactive gas encapsulation and release from echogenic liposomes.
2015. University of Cincinnati, Doctoral dissertation.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=ucin1429272100.
MLA Style (8th edition)
Raymond, Jason. "Bioactive gas encapsulation and release from echogenic liposomes." Doctoral dissertation, University of Cincinnati, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1429272100
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
ucin1429272100
Download Count:
1,149
Copyright Info
© 2015, all rights reserved.
This open access ETD is published by University of Cincinnati and OhioLINK.